Navigation Links
Synthetic Biology Scorecard finds federal agencies responding to bioethics report
Date:7/16/2012

WASHINGTON Federal agencies have started taking steps to address the recommendations in a 2010 report from the presidential bioethics commission to improve the governance of synthetic biology research and development, though the government has not fully addressed any of the report recommendations, according to a scorecard tracking the efforts.

The Synthetic Biology Project at the Woodrow Wilson International Center for Scholars launched the web-based Synthetic Biology Scorecard in February to track federal and non-federal efforts to implement the recommendations in New Directions: The Ethics of Synthetic Biology and Emerging Technologies, a December 2010 report from the Presidential Commission for the Study of Bioethical Issues. The recommendations seek to minimize risks from the technology while ensuring that social and economic benefits are realized.

Eighteen months after the release of the report, information collected by the Project and submitted by users finds that steps have been taken by the U.S. government over the past four months to continue addressing the report recommendations. These measures include a new White House-led interagency working group looking at government work on the issue; a recent six-party meeting at the National Academy of Sciences (the last in a series of three meetings between the United States, United Kingdom and China); and the development and release of the National Bioeconomy Blueprint.

Still, the Scorecard finds that none of the recommendations have been fully addressed, including six recommendations that called for federal action within 18 months, or by mid-June 2012. Of the six recommendations calling for action within 18 months, five of the recommendations saw some level of government activity.

Of the 17 recommendations tracked by the Scorecard, 13 had some level of federal activity and four had no activity, including a recommendation calling for risk assessments before research organisms or commercial products involving the technology are released into the environment and a recommendation calling for the identification of reliable containment and control mechanisms.

President Obama requested the Commission's report more than two years ago in response to important advancements in the field of synthetic biology. On May 20, 2010, scientists at the J.C. Venter Institute unveiled a bacterial cell controlled by a synthetic genome. The same day, the president asked the Commission to study "the implications of this scientific milestone . . . [and] consider the potential medical, environmental, security, and other benefits of this field of research, as well as any potential health, security, or other risks."

The Scorecard has new features to improve usability. People are encouraged to submit work by agencies, organizations, states and others that fulfill the Commission recommendations. The Project plans to continue to highlight the progress towards implementing the recommendations.


'/>"/>

Contact: Aaron Lovell
aaron.lovell@wilsoncenter.org
202-691-4320
Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program
Source:Eurekalert

Related biology news :

1. Synthetic diamond steps closer to next generation of high performance electrochemical applications
2. UC Santa Barbara researchers develop synthetic platelets
3. New synthetic biology technique boosts microbial production of diesel fuel
4. BWH launches a new research division focused on integrating systems biology and medicine
5. American Society for Microbiologys newest journal earns a high impact factor in latest rankings
6. Cell biology -- new insights into the life of microtubules
7. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
8. Oligonucleotide Delivery: Biology, Engineering and Development Conference
9. GW announces creation of Computational Biology Institute to conduct integrated research
10. MARC travel award announced for the 2012 GSA Yeast Genetics and Molecular Biology Meeting
11. Infection biology: The elusive third factor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/11/2017)... 2017  Michael Johnson, co-founder of Visikol Inc. a company originally ... been named to the elite "Forbes 30 Under 30" list in ... people in 20 fields nationwide to be recognized as a leader ... were selected. ... is currently a PhD candidate at Rutgers University. ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... 2017 , ... The American Medical Informatics Association (AMIA) today ... Policy. Specifically, the nation’s leading informatics experts, said data sharing plans should be ... recommended that NIH earmark funding for researchers to produce and execute data sharing ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a ... The tremendous growth is accounted to two main factors. The first is ... expanding network of vendors supplying FireflySci products all around the world. , 2016 was ...
(Date:1/19/2017)... , Jan. 18, 2017 The ... reach USD 92.9 billion by 2025, according to ... Pharmaceutical industry has been adaptive of the function ... early as 2002. Among the services outsourced, clinical ... For instance, Johnson & Johnson was the first ...
Breaking Biology Technology: